Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect
Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect
复制标题
DOI:
10.1111/jth.13372
复制
发表时间:
2016-08-01
影响因子:
10.4
通讯作者:
Vicente, V.
中科院分区:
文献类型:
--
作者:
de la Morena-Barrio, M. E.;Martinez-Martinez, I.;Vicente, V.
Background Since the discovery of antithrombin deficiency, 50 years ago, few new thrombophilic defects have been identified, all with weaker risk of thrombosis than antithrombin deficiency.Objective To identify new thrombophilic mechanisms.Patients/methods We studied 30 patients with antithrombin deficiency but no defects in the gene encoding this key anticoagulant (SERPINC1).Results A high proportion of these patients (8/30: 27%) had increased hypoglycosylated forms of antithrombin. All N-glycoproteins tested in these patients (1-antitrypsin, FXI and transferrin) had electrophoretic, HPLC and Q-TOF patterns indistinguishable from those of the congenital disorders of glycosylation (rare recessive multisystem disorders). However, all except one had no mental disability. Moreover, intermittent antithrombin deficiency and hypoglycosylation was recorded in five out of these eight patients, all associated with moderate alcohol intake. Genetic analysis, including whole exome sequencing, revealed mutations in different genes involved in the N-glycosylation pathway.Conclusions Our study provides substantial and novel mechanistic insights into two disease processes, with potential implications for diagnosis and clinical care. An aberrant N-glycosylation causing a recessive or transient antithrombin deficiency is a new form of thrombophilia. Our data suggest that congenital disorders of glycosylation are probably underestimated, especially in cases with thrombosis as the main or only clinical manifestation.